Clofazimine for the treatment of multidrug-resistant tuberculosis
Închide
Conţinutul numărului revistei
Articolul precedent
Articolul urmator
310 0
SM ISO690:2012
LANGE, Christoph G., CHESOV, Dumitru, HEYCKENDORF, Jan. Clofazimine for the treatment of multidrug-resistant tuberculosis. In: Clinical Microbiology and Infection, 2019, nr. 2(25), pp. 128-130. ISSN 1198-743X. DOI: https://doi.org/10.1016/j.cmi.2018.11.010
EXPORT metadate:
Google Scholar
Crossref
CERIF

DataCite
Dublin Core
Clinical Microbiology and Infection
Numărul 2(25) / 2019 / ISSN 1198-743X /ISSNe 1469-0691

Clofazimine for the treatment of multidrug-resistant tuberculosis

DOI: https://doi.org/10.1016/j.cmi.2018.11.010

Pag. 128-130

Lange Christoph G.123, Chesov Dumitru14, Heyckendorf Jan1
 
1 Research Center Borstel,
2 University of Lübeck,
3 Karolinska Institutet, Stockholm,
4 ”Nicolae Testemițanu” State University of Medicine and Pharmacy
 
Disponibil în IBN: 4 mai 2021


Cuvinte-cheie
Antitubercular Agents, Clofazimine, Humans, tuberculosis, Multidrug-Resistant